DaVita Net Worth 2010-2023 | DVA

Interactive chart of historical net worth (market cap) for DaVita (DVA) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. DaVita net worth as of September 29, 2023 is $8.63B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.631B $11.610B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.448B 11.00
Quest Diagnostics (DGX) United States $13.677B 14.04
Chemed (CHE) United States $7.835B 27.02
Encompass Health (EHC) United States $6.732B 19.87
Option Care Health (OPCH) United States $5.819B 24.69
Elanco Animal Health (ELAN) United States $5.538B 11.02
Amedisys (AMED) United States $3.048B 19.96
LifeStance Health (LFST) United States $2.597B 0.00
RadNet (RDNT) United States $1.911B 78.31
Addus HomeCare (ADUS) United States $1.380B 23.93
U.S Physical Therapy (USPH) United States $1.375B 36.55
Pennant (PNTG) United States $0.332B 18.86
Aveanna Healthcare Holdings (AVAH) United States $0.227B 0.00
Atai Life Sciences (ATAI) Germany $0.214B 0.00
Novo Integrated Sciences (NVOS) United States $0.044B 0.00
Daxor (DXR) United States $0.044B 0.00
ATI Physical Therapy (ATIP) United States $0.037B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.028B 0.00
Psychemedics (PMD) United States $0.023B 0.00
Greenbrook TMS (GBNH) Canada $0.011B 0.00
Ontrak (OTRK) United States $0.004B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00